Primary modeling studies that are well structured and easy to use are needed for clinicians to reliably predict progression of diabetic retinopathy, need for treatment, and visual loss.
Deep learning is capable of automatically predicting OCT-equivalent measures of macula thickening from color fundus photos and could significantly benefit tele-ophthalmology.
Anti-vascular endothelial growth factor (VEGF) therapy is a viable alternative to panretinal photocoagulation (PRP) in eyes with proliferative diabetic retinopathy (PDR), according to a study.
Many glaucoma therapies do not act on the trabecular meshwork - yet it represents a target for innovative treatment options. Read about increasing the aqueous humor outflow in the trabecular meshwork to reduce intraocular pressure. Don't miss this Partner Perspective.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%
